Once-Nightly Sodium Oxybate for Narcolepsy

A journal club review of “Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in phase 3 randomized clinical trial in patients with narcolepsy,” by Kushida CA, et al.

EP1: Presentation: Improvement of Narcolepsy Symptoms with Once-Nightly Sodium Oxybate

December 22nd 2021

Sponsored by: Avadel

Dr Clete Kushida discusses the results of a phase 3 clinical trial that examined once-nightly sodium oxybate in patients with narcolepsy.

EP2: Key Takeaways and Management of Narcolepsy

January 5th 2022

Sponsored by: Avadel

Takeaways of the REST-ON clinical trial results as presented in Sleep that help clinicians learn more about the management of patients with narcolepsy.

EP3: Questions Regarding Once-Nightly Sodium Oxybate for Narcolepsy

January 12th 2022

Sponsored by: Avadel

Questions raised by a recent paper by Kushida CA, et al., highlighting symptom improvement with once-nightly sodium oxybate in patients with narcolepsy.

EP4: Adopting Once-Nightly Sodium Oxybate into Clinical Practice to Treat Narcolepsy

January 19th 2022

Sponsored by: Avadel

The potential benefits of integrating once-nightly sodium oxybate into routine clinical practice to help address treatment limitations for patients with narcolepsy.

EP5: Future Opportunities Using One-Nightly Sodium Oxybate for Narcolepsy Treatment

January 26th 2022

Sponsored by: Avadel

Important next steps studying once-nightly sodium oxybate and other therapies for narcolepsy treatment.